Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Renaissance Capital Greenwich Fund (NY: IPOS)
27.61 USD  +0.12 (+0.43%)
Streaming Delayed Price  /  Updated: 11:26 AM EDT, Jun 2, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Renaissance Capital Greenwich Fund
Sector
Exchange Traded NY
Net Assets 2.76M
Inception Date
Related Funds
Quote
Price 27.61
Volume 2,071
Last Trade Jun 02, 11:26am
Change (%)
+0.12 (0.43%)
Prev. Close 27.49
YTD %
+11.79%
Dividend Yield 0.76%
Performance
YTD
+2.91 (11.79%)
1 Month
+4.32 (18.54%)
3 Month
+2.54 (10.15%)
6 Month
+4.75 (20.79%)
1 Year
+6.55 (31.12%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight
Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, ... Read More
from Benzinga
PreMarket Prep Stock Of The Day: GAN Limited
Benzinga'sPreMarket Prepairs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders ... Read More
from Benzinga
Top News
More News
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Beyond Meat isn't the only IPO stock taking off – traders pick their favorites
Some of the youngest stocks on Wall Street are among the biggest winners. Bill Baruch of Blue Line Capital and Danielle Shay of Simpler Trading pick their favorites. Read More
from CNBC.com News
Carvana Rival Online Car Seller Vroom Files To Go Public
Online used automobile seller Vroom Inc. on Monday said it has filed with the United States Securities and Exchange Commission to go ... Read More
from Benzinga
Nasdaq To Restrict Chinese Listings With New Strict IPO Requirements: Report
Nasdaq Inc. (NASDAQ: NDAQ) is bringing in new restrictions on initial public offerings in a move to curb Chinese listings on its ... Read More
from Benzinga
Moderna To Raise $1.3B In A Public Offering As Coronavirus Vaccine Trials See Progress
Moderna Inc. (NASDAQ: MRNA) announcedMonday it is planning to raise more than $1.3 billion in a secondary public offering. What ... Read More
from Benzinga
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
How two traders are approaching 2019 IPO stocks in this uncertain environment
Select 2019 public market newcomers such as Beyond Meat, Uber and Lyft have reliable long-term prospects despite the market turbulence, traders say. Read More
from CNBC.com News
JD Plans To Kickstart Hong Kong IPO As US-Listed Chinese Firms Increasingly Look Toward Home
Following in the footsteps of its bigger rival Alibaba Group Holding Ltd – ADR (NYSE: BABA), JD.Com Inc (NASDAQ: JD) is planning ... Read More
from Benzinga
Carvana Rival Online Retailer Vroom Plans June IPO: Report
Online auto retailer Vroom Inc. is seeking to go public as soon as June, the Wall Street Journal reported Sunday. What ... Read More
from Benzinga
Tesla Prepares To Restart Production At Fremont Factory This Week: Report
Tesla Inc. (NASDAQ: TSLA) is looking to resume production at its Fremont manufacturing plant, the San Francisco Chronicle reported ... Read More
from Benzinga
Peloton could hit all-time highs after earnings, trader says. Here's one way to play it
With options traders expecting Peloton's stock to move modestly higher after Wednesday's earnings report, Todd Gordon of Ascent Wealth Partners lays out a potential trade on the fitness play. Read More
from CNBC.com News
Start-up gets $1 billion valuation virtually, as coronavirus shifts Silicon Valley hunt for IPO riches
When VAST Data became a unicorn, valued at over $1 billion, in April, it relied on virtual meetings with investors, as Silicon Valley VCs and the IPO market navigate Covid-19. Read More
from CNBC.com News
The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.